Methods | Six-week randomised, double-blind study. | |
Participants | Outpatients fulfilling DSM-III-R criteria for non-psychotic depressive episode (no longer than 5 months), with a score of at least 21 on the HDRS and no more than 2 previous antidepressive drugs given for the current episode and no medication for 3-5 days before first assessment. Age range: 25-50 years old. Exclusion criteria: psychotic state, significant past head injury, severe neurological disease of physical illness, history of drug addiction or alcoholism, ECT in the last year, suicide risk, or suicide attempt in the last year |
|
Interventions | Fluoxetine: 8 participants. Desipramine: 9 participants. Fluoxetine dose: 20 mg/day. Desipramine dose range: 125-200 mg/day. |
|
Outcomes | Hamilton Rating Scale for Depression (HDRS-17), CGI. | |
Notes | Funding: unclear | |
Risk of bias | ||
Item | Authors’ judgement | Description |
Allocation concealment? | Unclear | B - Unclear |